208 related articles for article (PubMed ID: 15544489)
1. Anti-genes: siRNA, ribozymes and antisense.
Scanlon KJ
Curr Pharm Biotechnol; 2004 Oct; 5(5):415-20. PubMed ID: 15544489
[TBL] [Abstract][Full Text] [Related]
2. Approaches for the sequence-specific knockdown of mRNA.
Scherer LJ; Rossi JJ
Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
[TBL] [Abstract][Full Text] [Related]
3. Future promise of siRNA and other nucleic acid based therapeutics for the treatment of chronic HCV.
Wilson JA; Richardson CD
Infect Disord Drug Targets; 2006 Mar; 6(1):43-56. PubMed ID: 16787303
[TBL] [Abstract][Full Text] [Related]
4. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.
Morishita R; Kaneda Y; Ogihara T
BioDrugs; 2003; 17(6):383-9. PubMed ID: 14614761
[TBL] [Abstract][Full Text] [Related]
6. Strategies to identify potential therapeutic target sites in RNA.
Lützelberger M; Kjems J
Handb Exp Pharmacol; 2006; (173):243-59. PubMed ID: 16594619
[TBL] [Abstract][Full Text] [Related]
7. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
8. Antisense approaches to the gene therapy of cancer--'Recnac'.
Gibson I
Cancer Metastasis Rev; 1996 Sep; 15(3):287-99. PubMed ID: 9034592
[TBL] [Abstract][Full Text] [Related]
9. Antisense- and RNA interference-based therapeutic strategies in allergy.
Popescu FD
J Cell Mol Med; 2005; 9(4):840-53. PubMed ID: 16364194
[TBL] [Abstract][Full Text] [Related]
10. Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition.
Pierce ML; Ruffner DE
Nucleic Acids Res; 1998 Nov; 26(22):5093-101. PubMed ID: 9801305
[TBL] [Abstract][Full Text] [Related]
11. Drugs made of RNA: development and application of engineered RNAs for gene therapy.
Drude I; Dombos V; Vauléon S; Müller S
Mini Rev Med Chem; 2007 Sep; 7(9):912-31. PubMed ID: 17897081
[TBL] [Abstract][Full Text] [Related]
12. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
13. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets.
Jarad G; Simske JS; Sedor JR; Schelling JR
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):415-21. PubMed ID: 12815338
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
15. Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
Saetrom P
Bioinformatics; 2004 Nov; 20(17):3055-63. PubMed ID: 15201190
[TBL] [Abstract][Full Text] [Related]
16. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
Bhindi R; Fahmy RG; Lowe HC; Chesterman CN; Dass CR; Cairns MJ; Saravolac EG; Sun LQ; Khachigian LM
Am J Pathol; 2007 Oct; 171(4):1079-88. PubMed ID: 17717148
[TBL] [Abstract][Full Text] [Related]
17. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.
Fokina AA; Stetsenko DA; François JC
Expert Opin Biol Ther; 2015 May; 15(5):689-711. PubMed ID: 25772532
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for autosomal dominant disorders of keratin.
Lewin AS; Glazer PM; Milstone LM
J Investig Dermatol Symp Proc; 2005 Oct; 10(1):47-61. PubMed ID: 16250209
[TBL] [Abstract][Full Text] [Related]
19. Ribozymes and siRNA for the treatment of diseases of the nervous system.
Wood MJ; Trülzsch B; Abdelgany A; Beeson D
Curr Opin Mol Ther; 2003 Aug; 5(4):383-8. PubMed ID: 14513681
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligodeoxynucleotide and ribozyme design.
Probst JC
Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
